587 related articles for article (PubMed ID: 23459490)
1. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus.
Tarus B; Bertrand H; Zedda G; Di Primo C; Quideau S; Slama-Schwok A
J Biomol Struct Dyn; 2015 Sep; 33(9):1899-912. PubMed ID: 25333630
[TBL] [Abstract][Full Text] [Related]
3. From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.
Dilly S; Fotso Fotso A; Lejal N; Zedda G; Chebbo M; Rahman F; Companys S; Bertrand HC; Vidic J; Noiray M; Alessi MC; Tarus B; Quideau S; Riteau B; Slama-Schwok A
J Med Chem; 2018 Aug; 61(16):7202-7217. PubMed ID: 30028133
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.
Terrier O; Dilly S; Pizzorno A; Chalupska D; Humpolickova J; Bouřa E; Berenbaum F; Quideau S; Lina B; Fève B; Adnet F; Sabbah M; Rosa-Calatrava M; Maréchal V; Henri J; Slama-Schwok A
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946802
[TBL] [Abstract][Full Text] [Related]
5. Non-Uniform and Non-Random Binding of Nucleoprotein to Influenza A and B Viral RNA.
Le Sage V; Nanni AV; Bhagwat AR; Snyder DJ; Cooper VS; Lakdawala SS; Lee N
Viruses; 2018 Sep; 10(10):. PubMed ID: 30257455
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.
Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.
Chenavas S; Crépin T; Delmas B; Ruigrok RW; Slama-Schwok A
Future Microbiol; 2013 Dec; 8(12):1537-45. PubMed ID: 24266354
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1.
Lin MI; Su BH; Lee CH; Wang ST; Wu WC; Dangate P; Wang SY; Huang WI; Cheng TJ; Lin OA; Cheng YS; Tseng YJ; Sun CM
Eur J Med Chem; 2015 Sep; 102():477-86. PubMed ID: 26310893
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
10. Influenza nucleoprotein: promising target for antiviral chemotherapy.
Cianci C; Gerritz SW; Deminie C; Krystal M
Antivir Chem Chemother; 2012 Jul; 23(3):77-91. PubMed ID: 22837443
[TBL] [Abstract][Full Text] [Related]
11. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export.
Zheng W; Fan W; Zhang S; Jiao P; Shang Y; Cui L; Mahesutihan M; Li J; Wang D; Gao GF; Sun L; Liu W
Cell Rep; 2019 May; 27(6):1875-1885.e5. PubMed ID: 31067470
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
13. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
14. Identification of influenza A nucleoprotein as an antiviral target.
Kao RY; Yang D; Lau LS; Tsui WH; Hu L; Dai J; Chan MP; Chan CM; Wang P; Zheng BJ; Sun J; Huang JD; Madar J; Chen G; Chen H; Guan Y; Yuen KY
Nat Biotechnol; 2010 Jun; 28(6):600-5. PubMed ID: 20512121
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G
J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684
[TBL] [Abstract][Full Text] [Related]
16. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Complex between the Nucleoprotein and PA(1-27) of Influenza A Virus Polymerase.
Vidic J; Noiray M; Bagchi A; Slama-Schwok A
Biochemistry; 2016 Aug; 55(31):4259-62. PubMed ID: 27431776
[TBL] [Abstract][Full Text] [Related]
18. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
[TBL] [Abstract][Full Text] [Related]
19. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
20. San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo.
Ma Q; Yu Q; Xing X; Liu S; Shi C; Luo J
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
